IntechOpen eBooks,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 27, 2024
The
advent
of
artificial
intelligence
(AI)
has
revolutionized
drug
repositioning,
transforming
it
into
an
indispensable
strategy
for
accelerating
discovery.
This
chapter
offers
in-depth
exploration
the
multifaceted
landscape
repositioning
in
AI
era,
emphasizing
profound
influence
on
this
domain
and
providing
a
roadmap
future
research.
Beginning
with
brief
summary
data
that
form
bedrock
field,
biomedical
databases
encompassing
drugs,
diseases,
molecular
targets,
clinical
are
introduced
detail.
Then
experimental
computational
approaches
underpin
further
dissected,
ranging
from
binding
assays
or
phenotypic
screening
to
multi-omics
methodologies
silico
technologies,
emphasis
AI-driven
methods.
Subsequently,
successful
cases
across
diverse
diseases
highlighted.
Finally,
importance
fully
leveraging
address
challenges
is
underscored.
Frontiers in Oncology,
Journal Year:
2025,
Volume and Issue:
15
Published: Feb. 7, 2025
This
review
summarizes
the
applications
and
research
progress
of
organoid
models
in
colorectal
cancer
research.
First,
high
incidence
mortality
rates
are
introduced,
emphasizing
importance
organoids
as
a
model.
Second,
this
provides
detailed
introduction
to
concept,
biological
properties,
organoids,
including
their
strengths
mimicking
structural
functional
aspects
organs.
article
further
analyzes
adult
stem
cell-derived
pluripotent
discusses
advancements
for
basic
research,
drug
development,
personalized
treatment
evaluation
prediction,
regenerative
medicine.
Finally,
prospects
applying
technology
its
significant
value
improving
patient
survival
rates.
In
conclusion,
systematically
explains
highlighting
tremendous
potential
promising
Chinese Medical Journal,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 25, 2025
Abstract
The
high
failure
rates
in
clinical
drug
development
based
on
animal
models
highlight
the
urgent
need
for
more
representative
human
biomedical
research.
In
response
to
this
demand,
organoids
and
organ
chips
were
integrated
greater
physiological
relevance
dynamic,
controlled
experimental
conditions.
This
innovative
platform—the
organoids-on-a-chip
technology—shows
great
promise
disease
modeling,
discovery,
personalized
medicine,
attracting
interest
from
researchers,
clinicians,
regulatory
authorities,
industry
stakeholders.
review
traces
evolution
organoids-on-a-chip,
driven
by
necessity
advanced
biological
models.
We
summarize
applications
of
simulating
pathological
phenotypes
therapeutic
evaluation
technology.
section
highlights
how
integrating
technologies
chips,
such
as
microfluidic
systems,
mechanical
stimulation,
sensor
integration,
optimizes
organoid
cell
types,
spatial
structure,
functions,
thereby
expanding
their
applications.
conclude
addressing
current
challenges
offering
insights
into
prospects.
advancement
is
poised
enhance
fidelity,
standardization,
scalability.
Furthermore,
integration
cutting-edge
interdisciplinary
collaborations
will
be
crucial
progression
Molecular Medicine,
Journal Year:
2025,
Volume and Issue:
31(1)
Published: March 3, 2025
Abstract
As
an
emerging
technology,
organoids
are
promising
new
tools
for
basic
and
translational
research
in
disease.
Currently,
the
culture
of
relies
mainly
on
a
type
unknown
composition
scaffold,
namely
Matrigel,
which
may
pose
problems
studying
effect
mechanical
properties
organoids.
Hydrogels,
material
with
adjustable
properties,
can
adapt
to
current
studies.
In
this
review,
we
summarized
synthesis
recent
advance
developing
definite
hydrogel
scaffolds
organoid
identified
critical
parameters
regulating
properties.
addition,
classified
by
different
like
stiffness
viscoelasticity,
concluded
development
tumor
We
hope
review
enhances
understanding
hydrogels
provides
more
practical
approaches
investigating
them.
Nano Letters,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 13, 2025
Life
is
inherently
heterogeneous,
and
visualizing
this
heterogeneity
in
the
spatial
distribution
of
biometals
offers
valuable
insights
into
various
biological
processes.
While
biometal
mapping
provides
superior
resolution
compared
to
other
bioanalytical
techniques,
it
alone
cannot
fully
explain
functional
roles
health
disease.
In
study,
we
introduced
a
novel
method
using
specially
designed
sample
grids
facilitate
beam-,
X-ray-,
ion-beam-based
imaging
on
same
tissue
section.
This
innovative
approach
aligns
integrates
nanoscale-resolved
iron
profiles
across
spatial,
chemical,
isotopic
dimensions.
By
combining
these
analyses,
achieved
unprecedented
detail,
revealing
complex
regulatory
framework
homeostasis
liver
tissues
following
overload.
These
findings
demonstrate
that
enhancing
both
information
content
analysis
can
overcome
current
limitations,
providing
new
molecular
mechanisms
underlying
functions.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 25, 2025
The
persistently
high
mortality
rates
associated
with
cancer
underscore
the
imperative
need
for
innovative,
efficacious,
and
safer
therapeutic
agents,
as
well
a
more
nuanced
understanding
of
tumor
biology.
Patient-derived
organoids
(PDOs)
have
emerged
innovative
preclinical
models
significant
translational
potential,
capable
accurately
recapitulating
structural,
functional,
heterogeneous
characteristics
primary
tumors.
When
integrated
cutting-edge
genomic
tools
such
CRISPR,
PDOs
provide
powerful
platform
identifying
driver
genes
novel
targets.
This
comprehensive
review
delves
into
recent
advancements
in
CRISPR-mediated
functional
screens
leveraging
across
diverse
types,
highlighting
their
pivotal
role
high-throughput
genomics
microenvironment
(TME)
modeling.
Furthermore,
this
highlights
synergistic
potential
integrating
CRISPR
immunotherapy,
focusing
on
uncovering
immune
evasion
mechanisms
improving
efficacy
immunotherapeutic
approaches.
Together,
these
technologies
offer
promise
advancing
precision
oncology.
npj Precision Oncology,
Journal Year:
2025,
Volume and Issue:
9(1)
Published: March 29, 2025
Head
and
neck
squamous
cell
carcinoma
(HNSCC)
is
the
sixth
most
common
cancer
worldwide,
significantly
impacting
patient
survival
quality
of
life.
The
recent
emergence
immunotherapy
has
provided
new
hope
for
HNSCC
patients,
improving
rates;
however,
only
15%–20%
patients
benefit,
side
effects
are
inevitable.
With
advancements
in
omics
technologies
growing
prevalence
bioinformatics
research,
immune
microenvironment
become
increasingly
well
understood,
molecular
mechanisms
underlying
responses
continue
to
be
elucidated.
In
this
review,
we
summarize
commonly
used
techniques
their
applications
research
immunotherapy,
including
predicting
enhancing
efficacy,
formulating
personalized
treatment
plans,
establishing
robust
preclinical
models,
identifying
targets.
Finally,
explore
future
perspective
terms
sequencing
samples,
data
integration
analysis,
emerging
technologies,
clinicopathological
features,
interdisciplinary
approaches.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: Nov. 12, 2024
The
tumor
microenvironment
(TME)
plays
a
crucial
role
in
cancer
development
and
metastasis.
This
review
summarizes
the
current
research
on
how
TME
promotes
metastasis
through
molecular
pathways,
focusing
key
components,
such
as
cancer-associated
fibroblasts,
immune
cells,
endothelial
cytokines,
extracellular
matrix.
Significant
findings
have
highlighted
that
alterations
cellular
communication
within
enable
cells
to
evade
surveillance,
survive,
invade
other
tissues.
highlights
roles
of
TGF-β
VEGF
signaling
promoting
angiogenesis
matrix
remodeling,
which
facilitate
Additionally,
we
explored
metabolic
reprogramming
stromal
influenced
by
nutrient
availability
TME,
drives
progression.
study
also
evaluated
therapeutic
strategies
targeting
these
interactions
disrupt
By
providing
multidisciplinary
perspective,
this
suggests
understanding
basis
can
lead
more
effective
therapies
identify
potential
avenues
for
future
research.
Future
should
prioritize
unraveling
complex
environment,
could
novel
personalized
treatments.
Moreover,
advancements
technologies
single-cell
analysis,
spatial
transcriptomics,
epigenetic
profiling
offer
promising
identifying
new
targets
improving
efficacy
immunotherapies,
particularly
context